Lifeboat Foundation

Additionally, some reports have suggested that then-President Woodrow Wilson downplayed the virus, but that is a “wrong and a false trope of popular history,” Markel said. Wilson, who would later contract the virus, was organizing and commanding the U.S. effort in World War I and once the war ended, he sailed for Paris, where he stayed until April of 1919 organizing a peace treaty and the League of Nations, Markel said.

“The federal government played a very small role in American public health during that era. It was primarily a city and state role and those agencies were hardly downplaying it,” he said.

Unlike today, there was no CDC or national public health department. The Food and Drug Administration existed but consisted of a very small group of men. Additionally, there were no antibiotics, intensive care units, ventilators, IV fluids or vaccines. “You got a bed or maybe nursing care,” Markel said.

From the Science of Beer to learning about the benefits of GMOs; Saskatchewan is celebrating science with exciting online events and activities that showcase the province’s bioscience sector. Ag-West Bio, Saskatchewan’s bioscience industry association, coordinates events with the help of a local committee.

Ag-West Bio President and CEO Karen Churchill says amid the COVID-19 pandemic, biotechnology is in the spotlight. “Saskatchewan organizations in our research cluster have joined the global effort to develop vaccines as well as preventative and treatment solutions to deal with the virus. As a community, we should take note of the achievements of our local scientists and companies. Global Biotech Week gives us an opportunity to give them a (virtual) pat on the back!”

The Government of Saskatchewan and the Cities of Regina and Saskatoon have proclaimed September 28 to October 4 as Global Biotech Week.

Frost & Sullivan’s recent analysis, Data Science Impacting the Pharmaceutical Industry, finds that data science tools are promising technologies transforming drug discovery costs, speed, and efficiency. When combined with other emerging tech areas, artificial intelligence (AI) technologies move…

Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare

SANTA CLARA, Calif., Sept. 29, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Data Science Impacting the Pharmaceutical Industry, finds that data science tools are promising technologies transforming drug discovery costs, speed, and efficiency. When combined with other emerging tech areas, artificial intelligence (AI) technologies move to the next phase of advancements. Hence, they are expected to witness adoption by pharma and biotech companies in the next four to five years. Further, with the COVID-19 pandemic, AI and machine learning (ML) can be used for drug research and clinical trials against the coronavirus to screen large databases and perform docking studies to identify existing potential drugs or design new drugs using advanced learning algorithms.

Continue reading “Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan” »

Activities will include experiments, live Q&A with scientists, demonstrations, performances, podcasts, behind-the-scenes tours and more — along with up-to-the-minute information on what researchers are learning about COVID-19.

WOODS HOLE, Mass. — The dialogue between neurons is of critical importance for all nervous system activities, from breathing to sensing, thinking to running. Yet neuronal communication is so fast, and at such a small scale, that it is exceedingly difficult to explain precisely how it occurs. A preliminary observation in the Neurobiology course at the Marine Biological Laboratory (MBL), enabled by a custom imaging system, has led to a clear understanding of how neurons communicate with each other by modulating the “tone” of their signal, which previously had eluded the field. The report, led by Grant F. Kusick and Shigeki Watanabe of Johns Hopkins University School of Medicine, is published this week in Nature Neuroscience.

In 2016 Watanabe, then on the Neurobiology course faculty, introduced students to the debate over how many synaptic vesicles can fuse in response to one action potential (see this 2-minute video for a quick brush-up on neurotransmission). To probe this controversy, they used a “zap-and-freeze” imaging technology conceived by co-authors M. Wayne Davis, Watanabe and Erik Jorgensen, and built by Leica for testing in the Neurobiology course. They zapped a neuron with electricity to induce an action potential, then quickly froze the neuron and took an image. They saw multiple vesicles fusing at once at many synapses, the first novel finding of this Nature Neuroscience report.

Continue reading “Tone of voice matters in neuronal communication” »

It doesn’t appear staff or patient information was compromised.

Health care provider Universal Health Services, one of the largest chains in the US, has been hit by an apparent ransomware attack, TechCrunch reported. UHS facilities in California, Florida, North Dakota, Arizona, and other locations began noticing problems early Sunday, with some locations reporting locked computers and phone systems.

Some UHS hospitals had to use pen and paper to file patient information as a result, according to NBC News.

Continue reading “Ransomware reportedly to blame for outage at US hospital chain” »

Helium is crucial for physics research and medical imaging, but consumer usage of helium balloons threatens supply. Could vacuum balloons save the day?

Researchers in Norway have opened a clinical trial testing the UV1 cancer vaccine in combination with the drugs Opdivo and Yervoy to treat mesothelioma.

SLAC invention uses terahertz radiation to power a miniscule copper accelerator structure.

Particle accelerators generate high-energy beams of electrons, protons and ions for a wide range of applications, including particle colliders that shed light on nature’s subatomic components, X-ray lasers that film atoms and molecules during chemical reactions and medical devices for treating cancer.

As a rule of thumb, the longer the accelerator, the more powerful it is. Now, a team led by scientists at the Department of Energy’s SLAC National Accelerator Laboratory has invented a new type of accelerator structure that delivers a 10 times larger energy gain over a given distance than conventional ones. This could make accelerators used for a given application 10 times shorter.